↑ Cosnier, D.; Duchene-Marullaz, P.; Grimal, J.; Rispat, G.; Streichenberger, G. (1975). “Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (Tolonidine), a new antihypertensive agent. I. Action on blood pressure and heart rate”. Arzneimittel-Forschung 25 (10): 1557–61. PMID1243037.
↑ Cosnier, D.; Labrid, C.; Rispat, G.; Streichenberger, G. (1975). “Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. II. Action on cardiac contraction, circulatory parameters, autonomic receptors and diuresis”. Arzneimittel-Forschung 25 (11): 1802–6. PMID1243090.
↑ Cosnier, D.; Hache, J.; Labrid, C.; Streichenberger, G. (1975). “Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. III. Action on the secretions of the digestive tract and on the central nervous system, acute toxicity”. Arzneimittel-Forschung 25 (12): 1926–33. PMID3186.
